Growth Metrics

Maravai Lifesciences Holdings (MRVI) Income from Non-Controlling Interests (2020 - 2025)

Maravai Lifesciences Holdings has reported Income from Non-Controlling Interests over the past 6 years, most recently at -$27.3 million for Q4 2025.

  • Quarterly results put Income from Non-Controlling Interests at -$27.3 million for Q4 2025, down 35.57% from a year ago — trailing twelve months through Dec 2025 was -$100.0 million (up 12.88% YoY), and the annual figure for FY2025 was -$100.0 million, up 12.88%.
  • Income from Non-Controlling Interests for Q4 2025 was -$27.3 million at Maravai Lifesciences Holdings, down from -$19.5 million in the prior quarter.
  • Over the last five years, Income from Non-Controlling Interests for MRVI hit a ceiling of $85.5 million in Q2 2022 and a floor of -$75.4 million in Q3 2024.
  • Median Income from Non-Controlling Interests over the past 5 years was -$4.7 million (2023), compared with a mean of $16.2 million.
  • Biggest five-year swings in Income from Non-Controlling Interests: soared 449131.58% in 2021 and later plummeted 772.47% in 2024.
  • Maravai Lifesciences Holdings' Income from Non-Controlling Interests stood at $71.3 million in 2021, then crashed by 30.14% to $49.8 million in 2022, then crashed by 108.08% to -$4.0 million in 2023, then plummeted by 401.17% to -$20.2 million in 2024, then tumbled by 35.57% to -$27.3 million in 2025.
  • The last three reported values for Income from Non-Controlling Interests were -$27.3 million (Q4 2025), -$19.5 million (Q3 2025), and -$30.2 million (Q2 2025) per Business Quant data.